Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
7 USD | -0,99 % | -11,39 % | -11,17 % |
Métier
Nombre d'employés: 24
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01/11/18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02/03/22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08/02/22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01/11/18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26/04/19 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13/04/18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11/12/15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07/07/21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15/09/15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31/10/17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20/04/20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20/04/20 |
Julia Haller
BRD | Director/Board Member | 69 | 11/08/22 |
Director/Board Member | 39 | 11/09/17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19/06/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 23 405 637 | 14 743 307 ( 62,99 %) | 0 | 62,99 % |
Coordonnées société
Outlook Therapeutics, Inc.
111 South Wood Avenue Unit 100
08830, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-11,17 % | 164 M | |
+48,64 % | 56,65 Md | |
-6,44 % | 39,44 Md | |
+37,07 % | 39,03 Md | |
+14,28 % | 26,75 Md | |
-11,17 % | 26,86 Md | |
-21,40 % | 19,03 Md | |
+25,64 % | 12,26 Md | |
+0,96 % | 12,28 Md | |
+27,04 % | 12,04 Md |
- Bourse
- Actions
- Action OTLK
- Société Outlook Therapeutics, Inc.